NCCN 2012 Webinar Series: Sarcomas™: Systemic Therapy for the Initial Management of Bone Cancers
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this webinar, participants should be able to:
- Discuss the evidence supporting the use of neoadjuvant and adjuvant chemotherapy in the initial management of patients with localized bone sarcomas
- Summarize the treatment options for the management of patients with metastatic disease at initial presentation and identify the prognostic factors associated with favorable outcome in this group of patients
- Review the clinical evidence from ongoing trials evaluating novel systemic therapy options for patients with bone sarcomas
Robert S. Benjamin, MD
The University of Texas MD Anderson Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician